{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T23:06:55Z","timestamp":1787872015106,"version":"build-2784847793"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH\/NIAID","award":["U54AI-065357"],"award-info":[{"award-number":["U54AI-065357"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.antiviral.2016.04.013","type":"journal-article","created":{"date-parts":[[2016,5,5]],"date-time":"2016-05-05T07:03:48Z","timestamp":1462431828000},"page":"92-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["A humanized monoclonal antibody neutralizes yellow fever virus strain 17D-204 in\u00a0vitro but does not protect a mouse model from disease"],"prefix":"10.1016","volume":"131","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2803-0354","authenticated-orcid":false,"given":"Amanda E.","family":"Calvert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kandice L.","family":"Dixon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Piper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan L.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett A.","family":"Thibodeaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan D.T.","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T.","family":"Roehrig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol D.","family":"Blair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2016.04.013_bib2","doi-asserted-by":"crossref","first-page":"e1002930","DOI":"10.1371\/journal.ppat.1002930","article-title":"Structural basis of differential neutralization of DENV-1 genotypes by an antibody that recognizes a cryptic epitope","volume":"8","author":"Austin","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2016.04.013_bib3","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1016\/j.vaccine.2006.12.015","article-title":"17D yellow fever vaccines: new insights: a report of a workshop held during the world congress on medicine and health in the tropics, marseille, France, Monday 12 September 2005","volume":"25","author":"Barrett","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2016.04.013_bib4","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1128\/AAC.01178-09","article-title":"Safety and pharmacokinetics of single intravenous dose of MGAWN1, a novel monoclonal antibody to West Nile virus","volume":"54","author":"Beigel","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.04.013_bib5","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1099\/0022-1317-67-2-229","article-title":"Lethal 17D yellow fever encephalitis in mice. I. Passive protection by monoclonal antibodies to the envelope proteins of 17D yellow fever and dengue 2 viruses","volume":"67","author":"Brandriss","year":"1986","journal-title":"J.\u00a0General Virol."},{"key":"10.1016\/j.antiviral.2016.04.013_bib6","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1099\/0022-1317-66-12-2523","article-title":"Neutralization of yellow fever virus studied using monoclonal and polyclonal antibodies","volume":"66","author":"Buckley","year":"1985","journal-title":"J.\u00a0General Virol."},{"key":"10.1016\/j.antiviral.2016.04.013_bib7","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0042-6822(86)90298-9","article-title":"Topographical analysis of epitope relationships on the envelope glycoprotein of yellow fever 17D vaccine and the wild type asibi parent virus","volume":"150","author":"Cammack","year":"1986","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2016.04.013_bib8","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0140-6736(14)61060-6","article-title":"Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial","volume":"384","author":"Capeding","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2016.04.013_bib9","first-page":"643","article-title":"Fever, jaundice, and multiple organ system failure associated with 17D-derived yellow fever vaccination, 1996-2001","volume":"50","author":"CDC","year":"2001","journal-title":"MMWR. Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.antiviral.2016.04.013_bib10","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1146\/annurev.mi.44.100190.003245","article-title":"Flavivirus genome organization, expression, and replication","volume":"44","author":"Chambers","year":"1990","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.antiviral.2016.04.013_bib11","first-page":"75","article-title":"Changed virulence of the yellow fever virus vaccine strain 17D by a single mouse passage","volume":"11","author":"Collier","year":"1959","journal-title":"Trop. Geogr. Med."},{"key":"10.1016\/j.antiviral.2016.04.013_bib12","doi-asserted-by":"crossref","first-page":"7769","DOI":"10.1128\/JVI.75.16.7769-7773.2001","article-title":"Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to vero cells","volume":"75","author":"Crill","year":"2001","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.04.013_bib13","doi-asserted-by":"crossref","first-page":"e1002111","DOI":"10.1371\/journal.ppat.1002111","article-title":"A\u00a0dynamic landscape for antibody binding modulates antibody-mediated neutralization of West Nile virus","volume":"7","author":"Dowd","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2016.04.013_bib14","doi-asserted-by":"crossref","first-page":"12941","DOI":"10.1128\/JVI.77.24.12941-12949.2003","article-title":"Antibody prophylaxis and therapy against West Nile virus infection in wild-type and immunodeficient mice","volume":"77","author":"Engle","year":"2003","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.04.013_bib15","doi-asserted-by":"crossref","first-page":"e1001638","DOI":"10.1371\/journal.pmed.1001638","article-title":"Yellow fever in Africa: estimating the burden of disease and impact of mass vaccination from outbreak and serological data","volume":"11","author":"Garske","year":"2014","journal-title":"PLoS Med."},{"key":"10.1016\/j.antiviral.2016.04.013_bib16","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1099\/0022-1317-67-3-591","article-title":"Neutralizing (54K) and non-neutralizing (54K and 48K) monoclonal antibodies against structural and non-structural yellow fever virus proteins confer immunity in mice","volume":"67","author":"Gould","year":"1986","journal-title":"J.\u00a0General Virol."},{"key":"10.1016\/j.antiviral.2016.04.013_bib17","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1099\/0022-1317-66-7-1369","article-title":"Examination of the immunological relationships between flaviviruses using yellow fever virus monoclonal antibodies","volume":"66","author":"Gould","year":"1985","journal-title":"J.\u00a0General Virol."},{"key":"10.1016\/j.antiviral.2016.04.013_bib18","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1128\/JCM.36.5.1277-1284.1998","article-title":"Recombinant mouse-human chimeric antibodies as calibrators in immunoassays that measure antibodies to Toxoplasma gondii","volume":"36","author":"Hackett","year":"1998","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2016.04.013_bib19","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1073\/pnas.84.7.2019","article-title":"Comparison of the virulent asibi strain of yellow fever virus with the 17D vaccine strain derived from it","volume":"84","author":"Hahn","year":"1987","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.antiviral.2016.04.013_bib20","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1099\/0022-1317-69-5-1105","article-title":"Antigenic structure of the Murray Valley encephalitis virus E glycoprotein","volume":"69","author":"Hawkes","year":"1988","journal-title":"J.\u00a0General Virol."},{"key":"10.1016\/j.antiviral.2016.04.013_bib21","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0065-3527(08)60263-8","article-title":"Epitope mapping of flavivirus glycoproteins","volume":"31","author":"Heinz","year":"1986","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.antiviral.2016.04.013_bib22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0065-3527(03)59003-0","article-title":"Flavivirus structure and membrane fusion","volume":"59","author":"Heinz","year":"2003","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.antiviral.2016.04.013_bib23","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1128\/JVI.74.7.3020-3028.2000","article-title":"Chimeric dengue type 2 (Vaccine Strain PDK-53)\/dengue type 1 virus as a potential candidate dengue type 1 virus vaccine","volume":"74","author":"Huang","year":"2000","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.04.013_bib24","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1128\/JVI.73.1.783-786.1999","article-title":"New mouse model for dengue virus vaccine testing","volume":"73","author":"Johnson","year":"1999","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.04.013_bib25","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.antiviral.2012.12.002","article-title":"Experimental therapies for yellow fever","volume":"97","author":"Julander","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.04.013_bib26","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.antiviral.2013.12.011","article-title":"Humanized monoclonal antibody 2C9-cIgG has enhanced efficacy for yellow fever prophylaxis and therapy in an immunocompetent animal model","volume":"103","author":"Julander","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.04.013_bib27","doi-asserted-by":"crossref","first-page":"12400","DOI":"10.1073\/pnas.0603488103","article-title":"West Nile virus in complex with the Fab fragment of a neutralizing monoclonal antibody","volume":"103","author":"Kaufmann","year":"2006","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.antiviral.2016.04.013_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.micinf.2010.09.005","article-title":"Molecular mechanisms involved in the early steps of flavivirus cell entry","volume":"13","author":"Kaufmann","year":"2011","journal-title":"Microbes Infect."},{"key":"10.1016\/j.antiviral.2016.04.013_bib29","doi-asserted-by":"crossref","first-page":"18950","DOI":"10.1073\/pnas.1011036107","article-title":"Neutralization of West Nile virus by cross-linking of its surface proteins with Fab fragments of the human monoclonal antibody CR4354","volume":"107","author":"Kaufmann","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.antiviral.2016.04.013_bib30","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.4049\/jimmunol.141.10.3606","article-title":"Protection of mice against Japanese encephalitis virus by passive administration with monoclonal antibodies","volume":"141","author":"Kimura-Kuroda","year":"1988","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.antiviral.2016.04.013_bib31","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.virol.2015.03.025","article-title":"Shake, rattle, and roll: impact of the dynamics of flavivirus particles on their interactions with the host","volume":"479\u2013480","author":"Kuhn","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2016.04.013_bib32","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0092-8674(02)00660-8","article-title":"Structure of dengue virus: implications for flavivirus organization, maturation, and fusion","volume":"108","author":"Kuhn","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2016.04.013_bib33","doi-asserted-by":"crossref","first-page":"13729","DOI":"10.1128\/JVI.02340-13","article-title":"The Fc Region of an antibody impacts the neutralization of West Nile viruses in different maturation states","volume":"87","author":"Lee","year":"2013","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.04.013_bib34","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/0042-6822(87)90141-3","article-title":"Location of a neutralization determinant in the E protein of yellow fever virus (17D vaccine strain)","volume":"161","author":"Lobigs","year":"1987","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2016.04.013_bib35","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1128\/JVI.06072-11","article-title":"Crystal structure of the Japanese encephalitis virus envelope protein","volume":"86","author":"Luca","year":"2012","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.04.013_bib36","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1128\/JVI.01950-12","article-title":"Structure of the St. Louis encephalitis virus postfusion envelope trimer","volume":"87","author":"Luca","year":"2013","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.04.013_bib37","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0140-6736(01)05327-2","article-title":"Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases","volume":"358","author":"Martin","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2016.04.013_bib38","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.4049\/jimmunol.132.3.1533","article-title":"Elucidation of the topography and determination of the protective epitopes on the E glycoprotein of Saint Louis encephalitis virus by passive transfer with monoclonal antibodies","volume":"132","author":"Mathews","year":"1984","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.antiviral.2016.04.013_bib39","doi-asserted-by":"crossref","first-page":"6986","DOI":"10.1073\/pnas.0832193100","article-title":"A\u00a0ligand-binding pocket in the dengue virus envelope glycoprotein","volume":"100","author":"Modis","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2016.04.013_bib40","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1128\/JVI.79.2.1223-1231.2005","article-title":"Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein","volume":"79","author":"Modis","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.04.013_bib41","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.antiviral.2007.10.009","article-title":"Treatment of yellow fever","volume":"78","author":"Monath","year":"2008","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.04.013_bib42","doi-asserted-by":"crossref","first-page":"919","DOI":"10.4269\/ajtmh.2010.10-0001","article-title":"Suspected yellow fever vaccine-associated viscerotropic adverse events (1973 and 1978), United States","volume":"82","author":"Monath","year":"2010","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2016.04.013_bib43","doi-asserted-by":"crossref","first-page":"12510","DOI":"10.1128\/JVI.00458-08","article-title":"Neuroadapted yellow fever virus strain 17D: a charged locus in domain III of the E protein governs heparin binding activity and neuroinvasiveness in the SCID mouse model","volume":"82","author":"Nickells","year":"2008","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.04.013_bib44","doi-asserted-by":"crossref","first-page":"12232","DOI":"10.1128\/JVI.77.22.12232-12242.2003","article-title":"Neuroadapted yellow fever virus 17D: determinants in the envelope protein govern neuroinvasiveness for SCID mice","volume":"77","author":"Nickells","year":"2003","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.04.013_bib45","series-title":"Negative Co-Receptors and Ligands","first-page":"105","article-title":"Fc\u03b3Rs in health and disease","author":"Nimmerjahn","year":"2011"},{"key":"10.1016\/j.antiviral.2016.04.013_bib46","doi-asserted-by":"crossref","first-page":"11467","DOI":"10.1128\/JVI.01125-06","article-title":"Crystal structure of the West Nile virus envelope glycoprotein","volume":"80","author":"Nybakken","year":"2006","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.04.013_bib47","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/nature03956","article-title":"Structural basis of West Nile virus neutralization by a therapeutic antibody","volume":"437","author":"Nybakken","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2016.04.013_bib48","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1128\/JVI.20.3.664-675.1976","article-title":"Segmented genome and nucleocapsid of La crosse virus","volume":"20","author":"Obijeski","year":"1976","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.04.013_bib49","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1146\/annurev-virology-031413-085453","article-title":"Vaccine development as a means to control dengue virus pathogenesis: do we know enough?","volume":"1","author":"Pierson","year":"2014","journal-title":"Annu. Rev. Virol."},{"key":"10.1016\/j.antiviral.2016.04.013_bib50","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.chom.2008.08.004","article-title":"Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: implications for vaccine development","volume":"4","author":"Pierson","year":"2008","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.antiviral.2016.04.013_bib51","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.coviro.2012.12.001","article-title":"Flaviviruses: braking the entering","volume":"3","author":"Pierson","year":"2013","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.antiviral.2016.04.013_bib52","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/375291a0","article-title":"The envelope glycoprotein from tick-borne encephalitis virus at 2A resolution","volume":"375","author":"Rey","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2016.04.013_bib53","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1126\/science.4023707","article-title":"Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution","volume":"229","author":"Rice","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2016.04.013_bib54","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0065-3527(03)59005-4","article-title":"Antigenic structure of flavivirus proteins","volume":"59","author":"Roehrig","year":"2003","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.antiviral.2016.04.013_bib55","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0042-6822(82)90346-4","article-title":"Antigenic analysis of the surface glycoproteins of a Venezuelan equine encephalomyelitis virus (TC-83) using monoclonal antibodies","volume":"118","author":"Roehrig","year":"1982","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2016.04.013_bib56","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1006\/viro.1998.9057","article-title":"Mutation in a 17D-204 vaccine substrain-specific envelope protein epitope alters the pathogenesis of yellow fever virus in mice","volume":"244","author":"Ryman","year":"1998","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2016.04.013_bib57","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/S0140-6736(12)61428-7","article-title":"Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial","volume":"380","author":"Sabchareon","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2016.04.013_bib58","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1371\/journal.ppat.0030020","article-title":"Characterization of a structural intermediate of flavivirus membrane fusion","volume":"3","author":"Stiasny","year":"2007","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2016.04.013_bib59","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1016\/j.vaccine.2012.03.003","article-title":"A\u00a0small animal peripheral challenge model of yellow fever using interferon-receptor deficient mice and the 17D-204 vaccine strain","volume":"30","author":"Thibodeaux","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2016.04.013_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2012.02.001","article-title":"A\u00a0humanized IgG but not IgM antibody is effective in prophylaxis and therapy of yellow fever infection in an AG129\/17D-204 peripheral challenge mouse model","volume":"94","author":"Thibodeaux","year":"2012","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.04.013_bib61","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0140-6736(01)05326-0","article-title":"Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases","volume":"358","author":"Vasconcelos","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2016.04.013_bib62","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa1411037","article-title":"Efficacy of a tetravalent dengue vaccine in children in latin America","volume":"372","author":"Villar","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.antiviral.2016.04.013_bib63","doi-asserted-by":"crossref","first-page":"4019","DOI":"10.1128\/JVI.06871-11","article-title":"Recombinant dengue type 2 viruses with altered E protein domain III epitopes are efficiently neutralized by human immune sera","volume":"86","author":"Wahala","year":"2012","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.04.013_bib64","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.virol.2012.03.003","article-title":"Antibodies targeting dengue virus envelope domain III are not required for serotype-specific protection or prevention of enhancement in\u00a0vivo","volume":"429","author":"Williams","year":"2012","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2016.04.013_bib70","unstructured":"Wkly Epidemiol Rec, Adverse events following yellow fever vaccination. Releve epidemiologique hebdomadaire \/ Section d'hygiene du Secretariat de la Societe des Nations = Weekly epidemiological record \/ Health Section of the Secretariat of the League of Nations 76, 217-218."},{"key":"10.1016\/j.antiviral.2016.04.013_bib65","doi-asserted-by":"crossref","first-page":"W34","DOI":"10.1093\/nar\/gkt382","article-title":"IgBLAST: an immunoglobulin variable domain sequence analysis tool","volume":"41","author":"Ye","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2016.04.013_bib66","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.virol.2010.03.038","article-title":"Role of BC loop residues in structure, function and antigenicity of the West Nile virus envelope protein receptor-binding domain III","volume":"403","author":"Zhang","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2016.04.013_bib67","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1086\/599794","article-title":"Development of resistance to passive therapy with a potently neutralizing humanized monoclonal antibody against West Nile virus","volume":"200","author":"Zhang","year":"2009","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.04.013_bib68","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nsmb.2463","article-title":"Cryo-EM structure of the mature dengue virus at 3.5-\u00c5 resolution","volume":"20","author":"Zhang","year":"2013","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.antiviral.2016.04.013_bib69","doi-asserted-by":"crossref","first-page":"6795","DOI":"10.1073\/pnas.1304300110","article-title":"Dengue structure differs at the temperatures of its human and mosquito hosts","volume":"110","author":"Zhang","year":"2013","journal-title":"Proc. Natl. Acad. Sci."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016635421630242X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016635421630242X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T22:35:27Z","timestamp":1692311727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016635421630242X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":69,"alternative-id":["S016635421630242X"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.04.013","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A humanized monoclonal antibody neutralizes yellow fever virus strain 17D-204 in\u00a0vitro but does not protect a mouse model from disease","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}